Literature DB >> 20713085

Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes.

Catherine E Hagan1, John F Neumaier, James O Schenk.   

Abstract

Altered serotonin (5-HT) signaling is implicated in several neuropsychiatric disorders, including depression, anxiety, obsessive-compulsive disorder, and autism. The 5-HT transporter (SERT) modulates 5-HT neurotransmission strength and duration. This is the first study using rotating disk electrode voltammetry (RDEV) to measure 5-HT clearance. SERT kinetics were measured in whole brain synaptosomes. Uptake kinetics of exogenous 5-HT were measured using glassy carbon electrodes rotated in 500 μL glass chambers containing synaptosomes from SERT-knockout (-/-), heterozygous (+/-), or wild-type (+/+) mice. RDEV detected 5-HT concentrations of 5nM and higher. Initial velocities were kinetically resolved with K(m) and V(max) values of 99±35 standard error of regression (SER) nM and 181±11 SER fmol/(s×mg protein), respectively in wild-type synaptosomes. The method enables control over drug and chemical concentrations, facilitating interpretation of results. Results are compared in detail to other techniques used to measure SERT kinetics, including tritium labeled assays, chronoamperometry, and fast scan cyclic voltammetry. RDEV exhibits decreased 5-HT detection limits, decreased vulnerability to 5-HT oxidation products that reduce electrode sensitivity, and also overcomes diffusion limitations via forced convection by providing a continuous, kinetically resolved signal. Finally, RDEV distinguishes functional differences between genotypes, notably, between wild-type and heterozygous mice, an experimental problem with other experimental approaches.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713085      PMCID: PMC2952731          DOI: 10.1016/j.jneumeth.2010.08.009

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  98 in total

1.  Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.

Authors:  Trent J Volz; M Kim; James O Schenk
Journal:  Synapse       Date:  2004-06-15       Impact factor: 2.562

2.  L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.

Authors:  Trent J Volz; James O Schenk
Journal:  Synapse       Date:  2004-12-01       Impact factor: 2.562

3.  The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.

Authors:  Seth D Norrholm; David B Horton; Linda P Dwoskin
Journal:  Neuropharmacology       Date:  2007-10-07       Impact factor: 5.250

Review 4.  Going with the flow: trafficking-dependent and -independent regulation of serotonin transport.

Authors:  Jennifer A Steiner; Ana Marin D Carneiro; Randy D Blakely
Journal:  Traffic       Date:  2008-04-28       Impact factor: 6.215

5.  Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.

Authors:  Trent J Volz; Sarah J Farnsworth; Shane D Rowley; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2008-06-30       Impact factor: 4.030

6.  Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.

Authors:  Bruno P Guiard; Denis J P David; Thierry Deltheil; Franck Chenu; Erwan Le Maître; Thibault Renoir; Isabelle Leroux-Nicollet; Pierre Sokoloff; Laurence Lanfumey; Michel Hamon; Anne M Andrews; René Hen; Alain M Gardier
Journal:  Int J Neuropsychopharmacol       Date:  2007-06-11       Impact factor: 5.176

7.  Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.

Authors:  Trent J Volz; Sarah J Farnsworth; Jill L King; Evan L Riddle; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2007-08-10       Impact factor: 4.030

8.  Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).

Authors:  Qian Li; Li Ma; Robert B Innis; Nicholas Seneca; Masanori Ichise; Henry Huang; Marc Laruelle; Dennis L Murphy
Journal:  J Pharmacol Exp Ther       Date:  2003-11-10       Impact factor: 4.030

Review 9.  Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.

Authors:  Michael H Bloch; Angeli Landeros-Weisenberger; Srijan Sen; Philip Dombrowski; Ben Kelmendi; Vladimir Coric; Christopher Pittenger; James F Leckman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

10.  Regulating the conducting states of a mammalian serotonin transporter.

Authors:  Michael W Quick
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

View more
  6 in total

1.  Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.

Authors:  Michael R Bruchas; Abigail G Schindler; Haripriya Shankar; Daniel I Messinger; Mayumi Miyatake; Benjamin B Land; Julia C Lemos; Catherine E Hagan; John F Neumaier; Albert Quintana; Richard D Palmiter; Charles Chavkin
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

2.  Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain.

Authors:  Kymry T Jones; Catherine Woods; Juan Zhen; Tamara Antonio; Kenneth D Carr; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-01-31       Impact factor: 5.372

3.  Molecular fMRI of Serotonin Transport.

Authors:  Aviad Hai; Lili X Cai; Taekwan Lee; Victor S Lelyveld; Alan Jasanoff
Journal:  Neuron       Date:  2016-10-20       Impact factor: 17.173

4.  The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.

Authors:  Catherine E Hagan; James O Schenk; John F Neumaier
Journal:  Synapse       Date:  2011-04-07       Impact factor: 2.562

5.  Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.

Authors:  Abigail G Schindler; Daniel I Messinger; Jeffrey S Smith; Haripriya Shankar; Richard M Gustin; Selena S Schattauer; Julia C Lemos; Nicholas W Chavkin; Catherine E Hagan; John F Neumaier; Charles Chavkin
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

6.  5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.

Authors:  Catherine E Hagan; Ross A McDevitt; Yusha Liu; Amy R Furay; John F Neumaier
Journal:  Synapse       Date:  2012-09-29       Impact factor: 2.562

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.